Probi CFO to resign
Henrik Lundkvist has decided to leave his position after four years as CFO at Probi AB (publ). Henrik will continue to work as CFO until a successor has started or at the latest at the end of the year.
"Henrik has been a valued and valuable member of the management team and I want to take the opportunity to thank him for the work he has done in recent years and the commitment he has shown," says CEO Anita Johansen.
Probi will immediately begin the recruitment process of a new CFO.
This information is information that Probi AB is obliged to make public according to the EU's Market Abuse Regulation. The information was submitted, through the care of the contact persons below, for publication on 5 July 2023 at 17.00 CET. This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
For further information, please contact:
Anita Johansen, CEO, Probi, Phone +46 (0)46 286 89 48, e-mail: [email protected]
ABOUT PROBI
Probi® is a global Group that focuses exclusively on research, manufacturing and delivery of probiotics in dietary supplements and food. The company has expertise in managing live bacteria from research through all stages of the manufacturing process and is dedicated to making the health-promoting benefits of probiotics available to people around the world. Since the company was founded in 1991 at Lund University in Sweden, Probi has expanded its operations to more than 40 markets and holds more than 400 patents worldwide. Probi had sales of SEK 618 m in 2022. Probi's shares are listed on Nasdaq Stockholm, Mid-cap, and there were around 3,700 shareholders on December 31, 2022.
